- > Cyagen and Lumiere Therapeutics Forge Strategic Partnership to Advance Commercialization of the enCas12Ultra Base Editing System
- > How to Treat Ulcerative Dermatitis in Mice?
- > How to Make A Lentiviral Overexpression Vector?
- > What are the Strategies for Gene Therapy?
- > BALB/c vs C57BL/6 Mice: Key Differences for Research Models
- > ROSA26: The ‘Safe Harbor’ Locus in the Mouse Genome
Most Popular
|
Research Trends
|
| New Addition to Ophthalmic Models: Autosomal Recessive Retinitis Pigmentosa (arRP) - Rho KO Mice |
| Jun 06, 2025 |
| Retinitis Pigmentosa (RP) is a group of inherited retinal degenerative diseases that affect over 1.5 million people worldwide. Read More > |
|
Research Trends
|
| World Thalassemia Day | Powerful Tool for Disease Research: Hbb-bs & Hbb-bt DKO Mouse Models |
| May 29, 2025 |
| May 8 marks World Thalassemia Day — a timely opportunity to introduce β-thalassemia, a hereditary blood disorder caused by reduced or absent synthesis of the β-globin chains of hemoglobin. Read More > |
|
Research Trends
|
| On Huntington's Disease Awareness Day: How Humanized Models Drive Therapeutic Innovation |
| May 23, 2025 |
| May 15 marks International Huntington's Disease Awareness Day — a date not only meant to raise public awareness for those affected but also to highlight the urgent need for breakthroughs in treating this devastating condition. Read More > |
|
Research Trends
|
| Gaa Knockout Mice: A Powerful Model for Accelerating Pompe Disease Research |
| May 15, 2025 |
| Imagine a disease where the very substance meant to fuel your body—glycogen—becomes a silent saboteur, accumulating in critical tissues and gradually stealing a patient's strength and mobility. Read More > |
|
Research Trends
|
| World Lupus Day Spotlight: SLE Animal Models Driving Mechanistic Insights and Therapeutic Innovation |
| May 09, 2025 |
| Recently, Fate Therapeutics announced that its allogeneic CAR-T cell therapy FT819, developed based on induced pluripotent stem cells (iPSCs), has been granted Regenerative Medicine Advanced Therapy (RMAT) designation by the FDA Read More > |
|
Research Trends
|
| Full-Spectrum SMA Models: Humanized Mice with Varying SMN2 Copy Numbers |
| Apr 30, 2025 |
| Spinal Muscular Atrophy (SMA) remains one of the most devastating genetic diseases affecting infants and children worldwide. Read More > |
|
Research Trends
|
| Validating GLP-1RA Therapy in Preclinical Mouse Models of Metabolic Dysfunction-Associated Steatohepatitis |
| Apr 25, 2025 |
| Discover how Cyagen's validated preclinical MASH mouse models are accelerating GLP-1RA therapeutic development through clinically relevant disease modeling and pharmacodynamic evaluation. Read More > |
|
Research Trends
Newsletter
|
| World Hemophilia Day | China Approves First AAV Gene Therapy Drug: How Humanized Animal Models Enable Breakthroughs in Rare Disease Treatment |
| Apr 17, 2025 |
| On April 10, China’s National Medical Products Administration (NMPA) officially approved Dalnacogene Pankparvovec Injection (brand name: XinJiuning, research code: BBM-H901) Read More > |
|
Research Trends
|
| Preliminary Data: Inducible PKD Mouse Model Shows Phenotype in as Fast as 3 Weeks |
| Apr 11, 2025 |
| ADPKD is the most common inherited kidney disorder worldwide and a major cause of end-stage kidney disease (ESKD). Read More > |
|
Research Trends
|
| HUGO Series Humanized Mice: Revolutionizing Antibody Discovery and Gene Therapy Research |
| Apr 03, 2025 |
| An exclusive interview with Dr. Yingbin (Marvin) Ouyang, Executive Vice President and Chief Scientific Officer at Cyagen, on breakthrough advancements in humanized genomic ortholog mouse models. Read More > |
